Patient-determined discontinuation of regular prophylaxis for severe haemophilia: the west of Scotland experience

被引：0
|
作者：
Mccaig, A
Chalmers, E
Tait, RC
机构：
[1] Glasgow Royal Infirm, Dept Haematol, Glasgow G4 0SF, Lanark, Scotland
[2] Royal Hosp Sick Children, Dept Haematol, Glasgow G3 8SJ, Lanark, Scotland
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2006年 / 133卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：87 / 88
页数：2
相关论文
共 37 条
  • [31] Real-world experience of emicizumab prophylaxis in children with severe haemophilia A: I year follow-up study in egypt
    Sherief, L.
    Hassan, A. S.
    Hamdy, M.
    Darwish, A.
    Nazim, A.
    Hussein, M. A.
    Elgendy, M. R.
    El-assy, O. A.
    HAEMOPHILIA, 2024, 30 : 121 - 121
  • [32] Individualized Prophylaxis with BAY 81-8973: Clinical Experience in an Italian Patient with Severe Hemophilia A
    Santoro, Rita Carlotta
    Iannaccaro, Piergiorgio
    BLOOD, 2017, 130
  • [33] Impact of intermediate-dose prophylaxis on progression of haemarthropathy in patients with severe haemophilia A: A 10-year, single-centre experience in Korea
    Kim, Ju Y.
    Lee, Da J.
    Chun, Tong J.
    You, Chur W.
    HAEMOPHILIA, 2018, 24 (06) : E402 - E409
  • [34] REAL-WORLD EXPERIENCE AFTER SWITCHING TO RIX-FP PROPHYLAXIS IN A PATIENT WITH HAEMOPHILIA B IN THE CONTEXT OF THE COVID-19 PANDEMIC
    Diaz Jordan, B. L.
    Yepez Espinales, V. B.
    Valverde Templado, A.
    Cebanu, T.
    Rodrigo Alvarez, M. C.
    Caballero Almodovar, M. L.
    Galan Fernandez, M. C.
    Bustamante Garcia, A.
    Diaz Martin, M. D.
    Bellon Ruiz, A.
    Torres Peinado, C.
    Galan Fernandez, R.
    de la Reina Tejado, M. J. Garcia
    Campillo Herreros, J.
    Cruz Lerida, M. C.
    Martinez Hurtado, M. L.
    Alvarez Roman, M. T.
    HAEMOPHILIA, 2021, 27 : 117 - 117
  • [35] Successful prophylaxis using activated prothrombin complex concentrates (aPCC) in a severe haemophilia A patient with inhibitor previously unresponsive to on-demand daily infusions of aPCC
    Furukawa, S.
    Nogami, K.
    Ogiwara, K.
    Yada, K.
    Shima, M.
    HAEMOPHILIA, 2017, 23 (05) : e481 - e484
  • [36] PATIENT EXPERIENCE WITH EFANESOCTOCOG ALFA: RESULTS FROM THE XTEND-1 PHASE 3 CLINICAL TRIAL EXIT INTERVIEWS IN PATIENTS WITH SEVERE HAEMOPHILIA A
    Wilson, A.
    Kragh, N.
    DiBenedetti, D.
    Pan-Petesch, B.
    Wynn, T.
    Neme, D.
    Willemze, A.
    HAEMOPHILIA, 2023, 29 : 137 - 138
  • [37] Exploring baseline characteristics, treatment decisions and patient-centred outcomes of people with severe haemophilia A receiving prophylaxis: Early findings from the multi-country 'Cost of Haemophilia: A Socioeconomic Survey III' (CHESS III) study
    Chowdary, Pratima
    Polito, Letizia
    Chafaie, Romain
    Moreno, Katya
    Blenkiron, Tom
    Burke, Tom
    Grazzi, Enrico Ferri
    HAEMOPHILIA, 2024, 30 : 165 - 167
1234